We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Japanese Drugmaker Eisai Handed 483 Due to Data Integrity, Quality Concerns
Japanese Drugmaker Eisai Handed 483 Due to Data Integrity, Quality Concerns
The FDA served drug manufacturer Japanese drugmaker Eisai a Form 483 after an inspection of its Baltimore, Maryland facility revealed recordkeeping and quality control issues that led to incomplete data and unrestricted access to computers.